Discovering new drugs is an expensive proposition. From 2012 to 2022, adjusting for inflation, spending on pharmaceutical research and development increased by almost half to roughly $250bn, according to Bernstein Research. Yet the number of novel drug approvals remained broadly flat. Artificial intelligence could help.
发现新药成本高昂。根据伯恩斯坦研究(Bernstein Research)的数据，2012年至2022年间，经通胀调整后，制药研发支出增加近一半，约达2500亿美元，但新药审批数量基本持平。人工智能或可提供助力。
您已阅读11%（428字），剩余89%（3433字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。